FDA Inspection 1199799 — Maryellen Fitzgerald, M.D.

Maryellen Fitzgerald, M.D. — FEI 3025159943

The FDA completed an inspection of Maryellen Fitzgerald, M.D. on March 10, 2023 in Watertown, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 10, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Watertown, MA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance